Detalhe da pesquisa
1.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
2.
Evolution of the HIV-1 Rev Response Element during Natural Infection Reveals Nucleotide Changes That Correlate with Altered Structure and Increased Activity over Time.
J Virol
; 93(11)2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867301
3.
HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.
Retrovirology
; 16(1): 40, 2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842941
4.
Measurement of HIV Rev-Rev Response Element Functional Activity.
Methods Mol Biol
; 2807: 175-194, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743229
5.
Machine Learning-based Analysis of Publications Funded by the National Institutes of Health's Initial COVID-19 Pandemic Response.
Open Forum Infect Dis
; 11(4): ofae156, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659624
6.
Analysis of National Institutes of Health Funding for the COVID-19 Pandemic.
Open Forum Infect Dis
; 11(3): ofae064, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533269
7.
Rev-Rev Response Element Activity Selection Bias at the HIV Transmission Bottleneck.
bioRxiv
; 2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066242
8.
Rev-Rev Response Element Activity Selection Bias at the Human Immunodeficiency Virus Transmission Bottleneck.
Open Forum Infect Dis
; 10(10): ofad486, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854107
9.
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
Sci Immunol
; 8(82): eadf0348, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821695
10.
HIV-1 Rev-RRE functional activity in primary isolates is highly dependent on minimal context-dependent changes in Rev.
Sci Rep
; 12(1): 18416, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319640
11.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.
Open Forum Infect Dis
; 9(8): ofac343, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35959207
12.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
medRxiv
; 2022 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411349
13.
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Lancet Respir Med
; 9(12): 1365-1376, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672949
14.
Sequence and Functional Variation in the HIV-1 Rev Regulatory Axis.
Curr HIV Res
; 18(2): 85-98, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31906839
15.
A novel retroviral vector system to analyze expression from mRNA with retained introns using fluorescent proteins and flow cytometry.
Sci Rep
; 9(1): 6467, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015546